3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumor
1
Interventions
tislelizumab
3
Injections
2
Fluorodeoxyglucose F18
2
tumor-cells apoptosis factor, human
1
toripalimab
1
tazemetostat
1
pembrolizumab
1
enzalutamide
1
envafolimab
1
cemiplimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Radiotherapy
1
Proton Therapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Doxorubicin
1
Cisplatin
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Solid Tumor
×
Off-Label Use
×
90 days
×
Clear all
NCT06956248
2026-05-13
IMPACT-INSPIRE
National Cancer Centre, Singapore
Recruiting
50 enrolled